Researcher Spotlight: Eduardo Chini, M.D., Ph.D.

Researcher Spotlight: Eduardo Chini, M.D., Ph.D.

Published on July 27, 2021 Eduardo Chini, M.D., Ph.D., Mayo Clinic   How did you first get involved in PKD research? Eduardo: I’ve trained with Dr. Thomas Dousa one of the found fathers of biochemical nephrology. He studied signal transduction in kidney disease...
When a Clinical Trial Fails

When a Clinical Trial Fails

Published on June 29, 2021 | On June 1, the STAGED-PKD study was halted due to an inability to meet futility criteria. The study was looking at an investigational drug called venglustat to treat ADPKD. Over 500 patients signed up to participate. What does it mean to...
Researcher Spotlight: Xiangqin Cui, Ph.D.

Researcher Spotlight: Xiangqin Cui, Ph.D.

Published on June 22, 2021 Xiangqin Cui, Ph.D., Emory University   How did you first get involved in PKD research? Xiangqin: When I was a postdoc in Dr. Gary Churchill’s lab at the Jackson Laboratory, Dr. Churchill had collaborations with Dr. Lisa Guay-Woodford...
Meet Our 2021 Patient Stakeholders

Meet Our 2021 Patient Stakeholders

Published May 25, 2021 | At the PKD Foundation, funding PKD research is one of our primary functions. Starting last year, caregiver or patient stakeholders joined the research grant review panel to evaluate applications from the patient perspective. We spoke to two of...
English Spanish